Martingale Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,574
Closed -$1.39M 803
2025
Q4
$1.39M Sell
14,574
-695
-5% -$68.1K 0.04% 399
2025
Q3
$1.49M Sell
15,269
-3,396
-18% -$352K 0.04% 397
2025
Q2
$2M Sell
18,665
-1,582
-8% -$160K 0.05% 305
2025
Q1
$2.04M Buy
20,247
+15,235
+304% +$1.53M 0.05% 291
2024
Q4
$448K Sell
5,012
-44
-0.9% -$3.87K 0.01% 625
2024
Q3
$424K Sell
5,056
-568
-10% -$44.8K 0.01% 664
2024
Q2
$433K Sell
5,624
-7,390
-57% -$541K 0.01% 629
2024
Q1
$891K Hold
13,014
0.02% 496
2023
Q4
$752K Sell
13,014
-168
-1% -$8.97K 0.02% 514
2023
Q3
$696K Buy
+13,182
New +$691K 0.01% 536
2019
Q1
Sell
-15,263
Closed -$540K 1007
2018
Q4
$540K Sell
15,263
-40
-0.3% -$1.45K 0.01% 847
2018
Q3
$590K Sell
15,303
-130,602
-90% -$4.56M 0.01% 821
2018
Q2
$4.77M Buy
+145,905
New +$4.4M 0.06% 326
2015
Q1
Sell
-84,949
Closed -$1.13M 865
2014
Q4
$1.13M Buy
+84,949
New +$1.09M 0.03% 482

Other funds holding BSX

Martingale Asset Management's BSX Position: Q1 2026 in Review

Martingale Asset Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 14,574 shares — an estimated $1.39M sold.

Martingale Asset Management first reported a position in BSX in Q4 2014 and held it in 14 quarters. The position peaked at $4.77M in Q2 2018. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Martingale Asset Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Martingale Asset Management sold 14,574 Boston Scientific shares in Q1 2026, an estimated $1.39M.
  • Martingale Asset Management first reported a position in Boston Scientific in Q4 2014 and held it in 14 quarters.
  • Martingale Asset Management's Boston Scientific position peaked at $4.77M in Q2 2018.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.